Illumina, Inc.
(NASDAQ : ILMN)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. -4.45%160.070.0%$1484.90m
NVAXNovavax, Inc. -6.32%84.6578.2%$581.13m
AMGNAmgen, Inc. -0.52%227.721.4%$512.75m
BIIBBiogen, Inc. -2.39%220.521.8%$496.77m
GILDGilead Sciences, Inc. 1.03%68.511.0%$492.03m
BNTXBioNTech SE -5.77%147.500.0%$413.51m
REGNRegeneron Pharmaceuticals, Inc. 1.14%621.402.7%$402.73m
ILMNIllumina, Inc. -3.81%365.943.3%$378.85m
VRTXVertex Pharmaceuticals, Inc. -0.23%228.081.9%$340.95m
SNSSSunesis Pharmaceuticals, Inc. -3.99%2.650.7%$185.24m
EXASEXACT Sciences Corp. -2.63%74.0317.9%$168.66m
ARNAArena Pharmaceuticals, Inc. -0.58%90.4813.7%$131.37m
INCYIncyte Corp. 0.04%74.792.4%$130.18m
ALNYAlnylam Pharmaceuticals, Inc. -1.37%136.418.2%$125.00m
BMRNBioMarin Pharmaceutical, Inc. 0.24%84.654.2%$103.18m

Company Profile

Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through Core Illumina segment, which serves customers in the research, clinical and applied markets, and enable the adoption of a variety of genomic solutions. The firm's products include instruments, kits and reagents, selection tools, and software and analysis. Its services include sequencing and microarray services; proactive instrument monitoring; and instrument services, training, and consulting. The company was founded by David R. Walt, John R. Stuelpnagel, Anthony W. Czarnik, Lawrence A. Bock, and Mark S. Chee in April 1998 and is headquartered in San Diego, CA.